The information contained in this prospectus is not complete and may be changed. Nosecurities may be sold pursuant to this prospectus until the registration statement filed with the Securities and Exchange Commission with respect to such securities has been declared effective. This prospectus is not an offer to sell thesesecurities and no offers to buy these securities are being solicited in any jurisdiction where their offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED MAY 2, 2022
PRELIMINARY PROSPECTUS
UP TO199,825,500 ORDINARY SHARES
OF
GOGORO INC.
This prospectus relates to the offer and sale by usof (i) 17,250,000 ordinary shares, par value $0.0001 per share (Ordinary Shares) of Gogoro Inc. (the Company) issuable upon the exercise of 17,250,000 redeemable warrants to purchase Ordinary Shares, which are exercisable ata price of $11.50 per share (the Public Warrants), and (ii) 9,400,00 Ordinary Shares issuable upon the exercise of 9,400,000 private placement warrants (the Private Placement Warrants, and together with the Public Warrants,the Warrants) held by certain affiliates of Poema Global Partners LLC (the Sponsor), which are exercisable at a price of $11.50 per share.
This prospectus also relates to the resale from time to time by the selling securityholders named in this prospectus or their permitted transferees (theSelling Securityholders) of (a) 29,482,000 Ordinary Shares (the PIPE Shares) purchased by certain investors (the PIPE Investors) on April 4, 2022 (the Closing Date) pursuant to separatesubscription agreements dated September 16, 2021, January 18, 2022 and March 21, 2022 (the PIPE Subscription Agreement), (ii) 125,668,500 Ordinary Shares beneficially owned by certain shareholders of the Company prior tothe Closing Date (Legacy Gogoro, and such Ordinary Shares, the Legacy Gogoro Shares) (inclusive of up to 7,075,741 Ordinary Shares issuable to such shareholders pursuant to the earnout provisions of the Merger Agreement (asdescribed herein), (iii) 8,625,000 Ordinary Shares issued to certain affiliates of the Sponsor (the Sponsor Shares, and together with the Legacy Gogoro Shares, the Affiliated Shares), and (iv) 9,400,000 Ordinary Sharesissuable upon the exercise of the Private Placement Warrants. The Ordinary Shares offered by the Selling Securityholders are identified in this prospectus as the Registered Shares (the Registered Shares). The Selling Securityholders may,or may not, elect to sell Registered Shares as and to the extent that they may individually determine. See the section entitled Plan of Distribution.
We will not receive any proceeds from any sale of Registered Shares by Selling Securityholders under this prospectus. We will receive proceeds from theexercise of the Warrants if the Warrants are exercised for cash. We will pay the expenses associated with registering the sales by the Selling Securityholders, as described in more detail in the section titled Use of Proceeds appearingelsewhere in this prospectus.
Of the 173,175,500 Ordinary Shares that may be offered or sold by the Selling Securityholders identified in thisprospectus, certain of our Selling Securityholders are subject to lock-up restrictions with respect to 154,654,239 of those shares, pursuant to our agreements further described in the sections titledCertain Relationships, Related Party and Other Transactions appearing elsewhere in this prospectus.
Our Ordinary Shares and Public Warrantsare currently traded on the Nasdaq Global Select Market (Nasdaq) under the symbols GGR and GGROW, respectively. Our Ordinary Shares and Public Warrants began trading on the Nasdaq on April 5, 2022. Theclosing price of our Ordinary Shares on the Nasdaq on April 29, 2022 was $6.10 per ordinary share.
We are an emerging growth company asdefined in the Jumpstart Our Business Startups Act of 2012, and are therefore eligible to take advantage of certain reduced reporting requirements otherwise applicable to other public companies.
We are also a foreign private issuer, as defined in the Exchange Act and are exempt from certain rules under the Exchange Act that imposecertain disclosure obligations and procedural requirements for proxy solicitations under Section 14 of the Exchange Act. In addition, our officers, directors and principal shareholders are exempt from the reporting and short-swingprofit recovery provisions under Section 16 of the Exchange Act. Moreover, we are not required to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered underthe Exchange Act.
Neither the U.S. Securities and Exchange Commission nor any state securities commission has approved or disapproved of thesesecurities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.
Investing in ourOrdinary Shares involves a high degree of risk. Before buying any Ordinary Shares you should carefully read the discussion of material risks of investing in such securities in Risk Factors beginning onpage 10 of this prospectus and other risk factors contained in the documents incorporated by reference herein..
The date of thisprospectus is , 2022.